Jenburkt Pharmaceuticals Ltd
524731NSE
₹0.00▲ +0.00 (+0.00%)
Mkt cap₹456 Cr
P/E14.30
Volume—
Day range—
52W range1,010 – 1,073.9
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
Jenburkt Pharmaceuticals Ltd (524731): company summary
Jenburkt Pharmaceuticals Ltd (524731) is a micro-cap Healthcare company valued at ₹456 crore operating in Pharmaceuticals on the NSE and BSE.
Jenburkt Pharmaceuticals Ltd (524731) is a micro-cap Healthcare company valued at ₹456 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing steadily at 9.3% a year over three years; profit grew 11.6% a year, ahead of revenue — margins are expanding. Return on equity is 20.2%.
- Valuation multiples
- The stock trades at 14.3 times earnings, a discount to the Healthcare median of 32.0, 2.33 times book value. It yields 2.0%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
52W₹1010
₹1074
Key numbers
Price-based figures are live; statement figures are from FY26, consolidated where filed.
Valuation
- Market cap
- ₹456 Cr
- P/E
- 14.3×
- P/B
- 2.3×
- P/S
- —
- EV/EBITDA
- —
- Earnings yield
- 7.0%
- Dividend yield
- 2.01%
- Fair value
Profitability
- ROE
- 20.2%
- ROCE
- 27.0%
- ROIC
- —
- ROA
- —
- Gross margin
- —
- Operating margin
- 27.0%
- Net margin
- 21.1%
- EPS (TTM/FY)
- ₹72.64
Growth
- Sales · last qtr YoY
- —
- Profit · last qtr YoY
- —
- Sales · 1Y
- —
- Profit · 1Y
- —
- Sales CAGR · 3Y / 5Y
- +9% / +10%
- Profit CAGR · 3Y / 5Y
- +12% / +17%
- EPS CAGR · 5Y
- +17%
- Sales CAGR · 10Y
- +7%
Balance sheet
- Debt / equity
- 0.01
- Net debt / EBITDA
- —
- Interest cover
- —
- Current ratio
- —
- Total debt
- ₹2 Cr
- Cash
- —
- Book value / share
- ₹446.5
- Free cash flow
- ₹13 Cr
Quality & trading
- Piotroski F-score
- —
- Altman Z
- —
- Cash conversion cycle
- 115 days
- Dividend payout
- 26%
- Delivery %
- —
- Volume vs 30D avg
- —
- Avg traded value
- —
- Face value
- ₹10.00
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Jenburkt Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Jenburkt Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedDr. Reddy's Laboratories LimitedCipla LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Jenburkt Pharmaceuticals Ltd with peers
Jenburkt Pharmaceuticals Ltd vs Sun Pharmaceutical Industries LimitedJenburkt Pharmaceuticals Ltd vs Divi's Laboratories LimitedJenburkt Pharmaceuticals Ltd vs Torrent Pharmaceuticals LimitedJenburkt Pharmaceuticals Ltd vs Laurus Labs LimitedJenburkt Pharmaceuticals Ltd vs Zydus Lifesciences LimitedJenburkt Pharmaceuticals Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Jenburkt Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing